Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Rising Healthcare Stocks to Watch Now
Wall Street Cheat Street
Sunday, August 4, 2013 - 11:24am
tags:
Bruker, Cempra, Charles River Laboratories
Pacific Biosciences: Higher Expectations Return As Support Grows For This Gene Sequencer
Seeking Alpha
Sunday, August 4, 2013 - 11:22am
tags:
Pacific Biosciences, gene sequencing
Income And Excitement Are Things Omeros Offers
Seeking Alpha
Sunday, August 4, 2013 - 11:20am
tags:
Omeros
Bears want to savage Teva Pharma
NASDAQ
Saturday, August 3, 2013 - 11:01am
tags:
Teva Pharmaceuticals, earnings
A Feeding Frenzy over ROR Gamma T Modulators
invivoblog
Saturday, August 3, 2013 - 10:58am
tags:
Teijin Pharma, Amgen
Wider-Than-Expected Loss at Momenta
Zacks
Saturday, August 3, 2013 - 10:56am
tags:
Momenta, earnings
Does Exact Sciences' $1B Valuation Foreshadow A Bright Future For TrovaGene?
Seeking Alpha
Saturday, August 3, 2013 - 10:37am
tags:
TrovaGene
Potential Paradigm Shifting Technology from a Small Biotech
Motley Fool
Saturday, August 3, 2013 - 10:36am
tags:
Sarepta Therapeutics, eteplirsen, muscular dystrophy, Duchenne Muscular Dystrophy
Cadence: Ofirmev Sales Are Very Strong; Patent Decision Could Come By Year-End
Seeking Alpha
Saturday, August 3, 2013 - 10:34am
tags:
Cadence Pharmaceuticals, Ofirmev, pain management
6 Oncology-Focused Biotech Growth Engines
Seeking Alpha
Saturday, August 3, 2013 - 10:33am
tags:
Celgene, Regeneron, Biogen Idec, Gilead Sciences, ONYX Pharmaceuticals, Celldex
Aeterna Initiates Phase III Study on AEZS-108
Yahoo/Zacks
Saturday, August 3, 2013 - 10:30am
tags:
Aeterna Zentaris, AEZS-108, endometrial cancer
Questcor Going Up Even After Earnings
Seeking Alpha
Saturday, August 3, 2013 - 10:29am
tags:
Questcor Pharmaceuticals, earnings
Wider-than-Expected Loss at Endocyte
Yahoo/Zacks
Saturday, August 3, 2013 - 10:28am
tags:
Endocyte, earnings
BioCryst: The Next Orphan Drug $1B+ Company
Seeking Alpha
Saturday, August 3, 2013 - 10:27am
tags:
Biocryst, BCX4161, angioedema
Biogen Idec Product Pipeline Will Propel It Higher
Seeking Alpha
Saturday, August 3, 2013 - 10:26am
tags:
Biogen Idec
Johnson & Johnson Receives Boost in This Key Market
Motley Fool
Saturday, August 3, 2013 - 10:24am
tags:
Stelara, psoriatic arthritis, JNJ
The Deal: Pfizer's 3-Way Split Preps Company Long Term
The Street
Saturday, August 3, 2013 - 10:17am
tags:
Pfizer
These Pharmaceutical Giants Are Teetering Dangerously Near The Patent Cliff
Motley Fool
Saturday, August 3, 2013 - 10:16am
tags:
Pfizer, Eli Lilly, Bristol-Myers Squibb, patent cliff
This Company Is Tackling Multiple Sclerosis Head On
Motley Fool
Saturday, August 3, 2013 - 10:15am
tags:
MS, multiple sclerosis, Genzyme, Lemtrada, Sanofi
Regeneron Pharmaceuticals Inc (REGN) Earnings Expected to Rise
Forbes
Saturday, August 3, 2013 - 10:14am
tags:
Regeneron, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.